Circulating extracellular vesicle characteristics differ between men and women following 12 weeks of concurrent exercise training
Physiological Reports · 2024-05 · 12 (9)
DOI: 10.14814/phy2.16016 ↗At a glance
Journal article in Physiological Reports, published online on 2024-05-02. Written by Christopher K Kargl and 11 co-authors. Institution: Neuromuscular Research Lab/Warrior Human Performance Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Major MEDLINE topics: Extracellular Vesicles, Resistance Training, MicroRNAs. Cited 25 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: United Kingdom Ministry of Defense.
Abstract (original language)
Concurrent resistance and endurance exercise training (CET) has well‐studied benefits; however, inherent hormonal and genetic differences alter adaptive responses to exercise between sexes. Extracellular vesicles (EVs) are factors that contribute to adaptive signaling. Our purpose was to test if EV characteristics differ between men and women following CET. 18 young healthy participants underwent 12‐weeks of CET. Prior to and following CET, subjects performed an acute bout of heavy resistance exercise (AHRET) consisting of 6 × 10 back squats at 75% 1RM. At rest and following AHRET, EVs were isolated from plasma and characteristics and miRNA contents were analyzed. AHRET elevated EV abundance in trained men only (+51%) and AHRET‐induced changes were observed for muscle‐derived EVs and microvesicles. There were considerable sex‐specific effects of CET on EV miRNAs, highlighted by larger variation following the 12‐week program in men compared to women at rest. Pathway analysis based on differentially expressed EV miRNAs predicted that AHRET and 12 weeks of CET in men positively regulates hypertrophy and growth pathways more so than in women. This report highlights sex‐based differences in the EV response to resistance and concurrent exercise training and suggests that EVs may be important adaptive signaling factors altered by exercise training.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Neuromuscular Research Lab/Warrior Human Performance Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Army Health and Performance Research, Army Headquarters, Andover, UK.
- Division of Surgery and Interventional Science, University College London, London, UK.
- Norwich Medical School, University of East Anglia, Norwich, UK.
- Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID profiles: Christopher K Kargl, Adam J Sterczala, Bradley C Nindl
Funding
- United Kingdom Ministry of Defense
Cite
APA
Kargl, C. K., Sterczala, A. J., Santucci, D., Conkright, W. R., Krajewski, K. T., Martin, B. J., Greeves, J. P., O'Leary, T. J., Wardle, S. L., Sahu, A., Ambrosio, F., & Nindl, B. C. (2024). Circulating extracellular vesicle characteristics differ between men and women following 12 weeks of concurrent exercise training. Physiological Reports, 12(9). https://doi.org/10.14814/phy2.16016
Vancouver
Kargl CK, Sterczala AJ, Santucci D, Conkright WR, Krajewski KT, Martin BJ, et al. Circulating extracellular vesicle characteristics differ between men and women following 12 weeks of concurrent exercise training. Physiological Reports. 2024;12(9). doi:10.14814/phy2.16016
BibTeX
@article{Kargl2024,
author = {Kargl, Christopher K and Sterczala, Adam J and Santucci, Daniella and Conkright, William R and Krajewski, Kellen T and Martin, Brian J and Greeves, Julie P and O'Leary, Thomas J and Wardle, Sophie L and Sahu, Amrita and Ambrosio, Fabrisia and Nindl, Bradley C},
title = {Circulating extracellular vesicle characteristics differ between men and women following 12 weeks of concurrent exercise training},
journal = {Physiological Reports},
year = {2024},
volume = {12},
number = {9},
doi = {10.14814/phy2.16016}
}
EUVIMED